Kansas · 2025-2026 Regular Session · Bill
SB 212: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
SB 212 is a bill introduced in the Kansas Senate on February 5, 2025. According to its official title, it concerns: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs. Primary sponsor: Dinah Sykes (Democratic). Most recent recorded action (April 10, 2026): Died in Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Dinah Sykes | Primary sponsor | Democratic | Senate | 21 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died in Committee
- Referred to Senate Committee on Financial Institutions and Insurance
- Introduced